EverydayHealthLogo
Dr. Mindie Nguyen, MD

Dr. Mindie Nguyen, MD

Stanford, CA

27 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Nguyen, Transplant Hepatologist in Stanford, CA?

    Dr. Mindie Nguyen, MD is a Transplant Hepatologist, who primarily practices in Stanford, CA with 2 additional practice locations. She has been practicing for over 27 years and is board certified by the American Board of Internal Medicine. Dr. Nguyen graduated from University of California and completed her residency at University of California, San Diego. Dr. Nguyen is fluent in English and Vietnamese, and is currently seeing new patients. Dr. Nguyen’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Nguyen’s office at (650) 723-4000.

    Where did Dr. Nguyen go to medical school and complete their residency?

    • Fellowship: Stanford University School of Medicine CA

    • Residency: University of California, San Diego

    • Medical School: University of California

    Is Dr. Nguyen board certified in Transplant Hepatologist?

    Yes, Dr. Mindie Nguyen, MD is board certified by the American Board of Internal Medicine since 2010

    What languages does Dr. Nguyen speak?

    Dr. Nguyen and their clinical team can communicate with patients in the following languages:

    • English

    • Vietnamese

    What conditions does Dr. Nguyen treat?

    As a Transplant Hepatologist, Dr. Nguyen diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Nguyen. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

    Also known as:

    • Chronic Hepatitis B
    • Hepatitis B
    • Long-term Hepatitis B
    • Persistent Hepatitis B
    • Hep B

    ICD-10 Codes:

    • B181: Chronic viral hepatitis B without delta-agent

    Also known as:

    • Cirrhosis
    • Primary biliary cholangitis
    • Alcoholic Cirrhosis with Fluid Buildup
    • Bile Duct Disease
    • Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
    • Alcohol Use Disorder (AUD)
    • Liver scarring
    • End-stage liver disease
    • Chronic liver failure
    • Primary biliary cirrhosis
    • PBC
    • Autoimmune bile duct disease
    • Alcoholic cirrhosis with ascites
    • Alcohol-induced cirrhosis with fluid
    • Liver scarring with abdominal fluid

    ICD-10 Codes:

    • K7460: Unspecified cirrhosis of liver
    • K743: Primary biliary cirrhosis
    • K7031: Alcoholic cirrhosis of liver with ascites

    Also known as:

    • Liver Transplant
    • Liver Transplantation
    • Hepatic Transplant
    • Liver Graft
    • New Liver

    ICD-10 Codes:

    • Z944: Liver transplant status

    Also known as:

    • Fatty Liver Disease
    • Other specified liver Disease
    • Liver Disease
    • Nonalcoholic Fatty Liver Disease (NAFLD) & NASH
    • Nonalcoholic Fatty Liver Disease & NASH in Children
    • NAFLD
    • NASH
    • Hepatic steatosis
    • Uncommon liver conditions
    • Rare liver diseases
    • Specific liver disorders
    • Hepatic illness
    • Liver condition

    ICD-10 Codes:

    • K760: Fatty (change of) liver, not elsewhere classified
    • K7689: Other specified diseases of liver
    • K769: Liver disease, unspecified

    Also known as:

    • Liver Cancer
    • Childhood Liver Cancer
    • Hepatic Cancer
    • Hepatocellular Carcinoma

    ICD-10 Codes:

    • C220: Liver cell carcinoma

    Also known as:

    • Other Specific Abnormal Blood Chemistry Results
    • Blood
    • Specified Blood Chemistry Imbalance
    • Unusual Blood Chemistry Findings
    • Specific Blood Panel Abnormalities

    ICD-10 Codes:

    • R7989: Other specified abnormal findings of blood chemistry

    Also known as:

    • Nonalcoholic steatohepatitis (NASH)
    • Fatty Liver Disease
    • Non-alcoholic fatty liver disease
    • Nonalcoholic Fatty Liver Disease (NAFLD) & NASH
    • Nonalcoholic Fatty Liver Disease & NASH in Children
    • NASH
    • Non-alcoholic fatty liver disease with inflammation
    • Fatty liver inflammation

    ICD-10 Codes:

    • K7581: Nonalcoholic steatohepatitis (NASH)

    Also known as:

    • History of liver cancer
    • Liver Cancer
    • Past liver cancer
    • Hepatic cancer survivor
    • Previous liver malignancy

    ICD-10 Codes:

    • Z8505: Personal history of malignant neoplasm of liver

    Also known as:

    • Other Abnormal Enzyme Levels
    • Unspecified high enzymes
    • Various enzyme abnormalities
    • Abnormal serum enzyme levels

    ICD-10 Codes:

    • R748: Abnormal levels of other serum enzymes

    Also known as:

    • Autoimmune hepatitis
    • Autoimmune Disease
    • Hepatitis
    • Autoimmune Hepatitis
    • AIH
    • Autoimmune liver disease
    • Chronic autoimmune hepatitis

    ICD-10 Codes:

    • K754: Autoimmune hepatitis

    Also known as:

    • Infectious and Parasitic Disease
    • Infectious Disease
    • Parasitic Disease
    • Communicable Diseases
    • Parasitic Infections
    • Contagious Diseases

    ICD-10 Codes:

    • Z8619: Personal history of other infectious and parasitic diseases

    Also known as:

    • Liver Fibrosis
    • Liver Disease
    • Hepatic scarring
    • Scarred liver
    • Fibrotic liver

    ICD-10 Codes:

    • K7400: Hepatic fibrosis, unspecified

    Also known as:

    • High Liver Enzymes
    • ALT Blood Test
    • AST Test
    • Elevated ALT
    • Elevated AST
    • Abnormal liver function test

    ICD-10 Codes:

    • R7401: Elevation of levels of liver transaminase levels

    Also known as:

    • Immune Deficiency
    • Immune System and Disorder
    • Weak Immune System
    • Immune System Disorder

    ICD-10 Codes:

    • D849: Immunodeficiency, unspecified

    Also known as:

    • Chronic Hepatitis C
    • Hepatitis C
    • Long-term Hepatitis C
    • Persistent Hepatitis C
    • Hep C

    ICD-10 Codes:

    • B182: Chronic viral hepatitis C

    Also known as:

    • Other Abnormal Immune System Markers
    • Unusual immune findings
    • Abnormal immunology results
    • Abnormal serum immunology

    ICD-10 Codes:

    • R768: Other specified abnormal immunological findings in serum

    Which procedures does Dr. Nguyen perform as a Transplant Hepatologist?

    As a Transplant Hepatologist, procedures performed by a Dr. Mindie Nguyen may include:

    For detailed information, please contact Dr. Nguyen's office.

    Does Dr. Nguyen accept my insurance?

    Dr. Nguyen accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Nguyen accept in Stanford, CA?

    Dr. Nguyen in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Alignment Health Plan

    • All Other Third Party

    • Blue Shield of California

    • Central California Alliance for Health

    • CVS Health (formerly Aetna)

    • Medicaid

    • Medicare

    • OptumRx

    • Santa Clara Family Health Plan

    • UnitedHealthcare

    View All Insurances

    Where is Dr. Nguyen's office located?

    Dr. Mindie Nguyen's Primary Practice

    300 Pasteur Dr

    Stanford, CA 94305

    (650) 723-4000

    Get Directions

    Dr. Mindie Nguyen's Practice 2

    5555 W Las Positas Blvd

    Pleasanton, CA 94588

    Get Directions

    Dr. Mindie Nguyen's Practice 3

    5800 Hollis St

    Emeryville, CA 94608

    Get Directions

    Recognitions

    Awards

    Chief Resident,

    University of California, San Diego Medical Center

    Cardinal Free Clinics, Stanford University School of Medicine

    Pacific Free Clinic Physician Service Award

    Stanford University School of Medicine

    The Franklin Edbaugh Advising Award for Faculty

    Phi Beta Kappa,

    University of California, Irvine

    Magna Cum Laude,

    University of California, Irvine

    Excellence in Teaching Award,

    University of California, San Diego, School of Medicine

    American Association for the Study of Liver Diseases

    Advanced Hepatology Research Fellow Award

    Stanford University Medical Center

    Chief Fellow in Gastroenterology and Hepatology

    Publications

    Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply.

    Alimentary pharmacology & therapeutics, 2014

    Treating hepatitis C in lower-income countries.

    New England jourl of medicine, 2014

    Commentary: tenofovir is superior to entecavir in HBeAg

    Alimentary pharmacology & therapeutics, 2014

    Letter: apoptosis and hepatic fibrosis in chronic hepatitis B - authors' reply.

    Alimentary pharmacology & therapeutics, 2014

    Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.

    New England jourl of medicine, 2014

    Systematic review with meta-alysis

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014

    Primary surgical resection versus liver transplantation for transplant

    Digestive diseases and sciences, 2014

    Current Treatment Guidelines for Chronic Hepatitis B and Their Applications.

    Jourl of clinical gastroenterology

    Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

    The New England jourl of medicine, 2014

    Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.

    The New England jourl of medicine, 2014

    Recurrent Hepatocellular Carcinoma

    Jourl of clinical gastroenterology

    Letter: treatment of HBeAg+ chronic hepatitis B

    Alimentary pharmacology & therapeutics, 2014

    Isoniazid Hepatotoxicity Requiring Liver Transplantation.

    Digestive diseases and sciences

    Approximately one-half of patients with early

    Cancer

    Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg

    Alimentary pharmacology & therapeutics

    Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment- < ve Chronic Hepatitis B Patients

    DIGESTIVE DISEASES AND SCIENCES, 2014

    Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014

    Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV

    DIGESTIVE DISEASES AND SCIENCES, 2014

    Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the

    Liver transplantation : official publication of the American Associati

    Chronic Hepatitis B Magement Based on Standard Guidelines

    DIGESTIVE DISEASES AND SCIENCES, 2013

    Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians.

    Jourl of immigrant and minority health, 2013

    Less-established risk factors are common in asian americans with hepatitis C virus

    Digestive diseases and sciences, 2013

    Prevalence, risk factors

    Jourl of cancer education, 2013

    Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy.

    Clinical gastroenterology and hepatology, 2013

    Systematic review: Asian patients with chronic hepatitis C infection.

    Alimentary pharmacology & therapeutics, 2013

    Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos

    Jourl of gastroenterology and hepatology, 2013

    Response to Higher Dose of Entecavir 1.0 mg Daily

    JOURL OF CLINICAL GASTROENTEROLOGY, 2013

    High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver

    JOURL OF CLINICAL GASTROENTEROLOGY, 2013

    Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long

    EUROPEAN JOURL OF GASTROENTEROLOGY & HEPATOLOGY, 2013

    Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013

    Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B

    Jourl of clinical gastroenterology

    Prevention of Mother-to-Child Transmission of Hepatitis B Virus

    Clinical gastroenterology and hepatology : the official clinical pract

    Histologic Changes in Liver Tissues from Patients with Chronic Hepatitis B

    Clinical gastroenterology and hepatology : the official clinical pract

    Mutations in HBV D Polymerase Associated with Nucleos(t)ide resistance are Rare in Treatment-ïve Pat

    Clinical gastroenterology and hepatology : the official clinical pract

    Increased Long-Term Survival Among Patients with Hepatocellular Carcinoma After Implementation of

    Clinical gastroenterology and hepatology : the official clinical pract

    Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral

    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012

    High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion

    JOURL OF CLINICAL GASTROENTEROLOGY, 2012

    Tenofovir Monotherapy

    DIGESTIVE DISEASES AND SCIENCES, 2012

    Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines

    DIGESTIVE DISEASES AND SCIENCES, 2012

    Risk factors for hepatocellular carcinoma in patients with chronic liver disease

    CANCER CAUSES & CONTROL, 2012

    Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic

    JOURL OF VIRAL HEPATITIS, 2012

    Ethnic differences in viral domince patterns in patients with hepatitis B virus

    Hepatology, 2012

    High Rate of Complete Viral Suppression With Combition Therapy

    JOURL OF CLINICAL GASTROENTEROLOGY, 2011

    The efficacy of entecavir therapy

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011

    Systematic review: epidemiology of hepatitis C genotype 6 and its magement

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011

    Medication Nodherence with Long-Term Magement of Patients with Hepatitis B e antigen

    DIGESTIVE DISEASES AND SCIENCES, 2011

    Ethnic Differences in Viral Domince Patterns in Patients with Hepatitis B Virus

    HEPATOLOGY, 2011

    Relationship between HBsAg seroconversion and hepatocellular carcinoma

    J Clin Gastroenterol, 2011

    Early virologic response in HCV genotype 6

    Hepatology, 2011

    The role of steatosis in HBV infection

    Curr Hepat Rep, 2011

    Hepatitis B virus reverse transcriptase sequence variant database for sequence alysis

    ANTIVIRAL RESEARCH, 2010

    Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment

    HEPATOLOGY, 2010

    Response to pegylated interferon

    JOURL OF VIRAL HEPATITIS, 2010

    Risk factors, genotype 6 prevalence

    HEPATOLOGY INTERTIOL, 2010

    Similar Treatment Response to Peginterferon and Ribavirin

    AMERICAN JOURL OF GASTROENTEROLOGY, 2010

    Histologic Disease in Patients with Chronic Hepatitis B, HIgh HBV D

    Curr Hepat Rep, 2010

    Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic

    DIGESTIVE DISEASES AND SCIENCES, 2009

    Prevalence of hepatitis B virus D polymerase mutations in treatment

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009

    Combition of pharmacologic

    GASTROINTESTIL ENDOSCOPY, 2009

    Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus D

    AMERICAN JOURL OF GASTROENTEROLOGY, 2009

    Rel Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil

    HEPATOLOGY, 2009

    Prevalence of hepatitis B virus genotype B in Vietmese patients with chronic hepatitis B

    HEPATOLOGY INTERTIOL, 2009

    alpha-Fetoprotein, Des-gamma Carboxyprothrombin

    GASTROENTEROLOGY, 2009

    Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy

    AMERICAN JOURL OF TRANSPLANTATION, 2009

    Clinical course of hepatitis B virus infection during pregncy

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009

    Chronic hepatitis B: early viral suppression and long

    JOURL OF VIRAL HEPATITIS, 2009

    Hepatitis C virus and cancers: How strong are the relationships?

    Curr Hepat Rep, 2009

    Prevalence of Colorectal Neoplasms in Asian Americans

    DIGESTIVE DISEASES AND SCIENCES, 2009

    Are Hepatitis B e Antigen

    CLINICAL INFECTIOUS DISEASES, 2008

    Low proportion of Barrett's esophagus in Asian Americans

    AMERICAN JOURL OF GASTROENTEROLOGY, 2008

    Higher rate of sustained virologic response

    AMERICAN JOURL OF GASTROENTEROLOGY, 2008

    Significant prevalence of histologic disease in patients with chronic hepatitis B

    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008

    Long-term survival of patients with unresectable hepatocellular carcinoma treated with

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007

    Chronic HBV infection and normal ALT levels: Underlying histological disease

    Curr Hepat Rep, 2007

    Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

    Clinical gastroenterology and hepatology, 2005

    Chronic hepatitis C: genotypes 4 to 9.

    Clinics in liver disease, 2005

    The diagnosis and magement of benign hepatic tumors

    JOURL OF CLINICAL GASTROENTEROLOGY, 2005

    General magement

    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY, 2005

    Benign tumors and evaluation of liver masses

    In: Al Kwy B, Schiffman ML, and Wiesner R, eds. Hepatology: A Practica

    Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C

    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004

    Use of endoclips in the treatment of massive colonic diverticular bleeding

    GASTROINTESTIL ENDOSCOPY, 2004

    Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9.

    Reviews in gastroenterological disorders, 2004

    Unsedated ultrathin EGD is well accepted when compared with conventiol sedated EGD

    GASTROENTEROLOGY, 2003

    Prophylactic clip application

    GASTROINTESTIL ENDOSCOPY, 2003

    Prophylaxis against chemotherapy

    JOURL OF CLINICAL GASTROENTEROLOGY, 2003

    Chronic hepatitis B and hepatitis C in Asian Americans.

    Reviews in gastroenterological disorders, 2003

    Treatment of Hepatocellular Carcinoma

    Rustgi AK and Crawford J, eds. Gastrointestil Cancer: A companion to S, 2003

    Screening for hepatocellular carcinoma

    JOURL OF CLINICAL GASTROENTEROLOGY, 2002

    Unsedated ultrathin EGD is well accepted by most patients

    Garcia, R. T., Cello, J. P., Rogers, S. J., Rodas, A., Nguyen, M. H., , 2002

    Racial differences in effectiveness of alpha

    HEPATOLOGY, 2002

    Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?

    AMERICAN JOURL OF GASTROENTEROLOGY, 2002

    Therapeutic advances in the magement of hepatitis B and hepatitis C

    CURRENT OPINION IN INFECTIOUS DISEASES, 2001

    DIFFERENTIAL MIGRATION OF ASTROCYTES GRAFTED INTO THE DEVELOPING RAT-BRAIN

    GLIA, 1993

    What is Dr. Nguyen's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Nguyen's National Provider Identifier (NPI) number is 1164558326.

    What common questions do patients ask about Dr. Nguyen?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Nguyen

    What is Dr. Mindie Nguyen's specialty?

    Dr. Nguyen is a Transplant Hepatologist near Stanford, CA. An internist with specialized knowledge and skills in gastroenterology, focusing on the comprehensive care of patients before and after liver transplantation, across all phases of the transplant process. The selection of suitable transplant candidates involves a multidisciplinary team experienced in assessing the severity and prognosis of liver disease to ensure optimal outcomes. Contact Dr. Nguyen to book an appointment today.

    Is this Dr. Mindie Nguyen affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Nguyen is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Transplant Hepatologist?

    Explore Transplant Hepatologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Mindie Nguyen accepting new patients in Stanford, CA?

    Yes, Dr. Mindie Nguyen is accepting new patients at this time.

    Does Dr. Mindie Nguyen offer online booking?

    Please contact Dr. Nguyen's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Mindie Nguyen?

    Please contact Dr. Nguyen's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Mindie Nguyen have?

    Dr. Mindie Nguyen is certified by the American Board of Internal Medicine.

    Other Transplant Hepatologist Near Stanford, CA

    Dr. Sajid Jalil, MD

    Transplant Hepatologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    RD
    acceptingPatients-iconAccepting patients
    Stanford, CA
    ND

    Gastroenterologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists